Trisenox 12 mg/6 ml
Trisenox 12 mg/6 ml is a medicine authorised by Swissmedic under authorisation number 65178. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 December 2014 and the authorisation is valid without a time limit. ATC code L01XX27 places the medicine in the group Antineoplastic agents.
| Authorisation number | 65178 |
|---|---|
| Name | Trisenox 12 mg/6 ml |
| Full name | Trisenox 12 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XX27 |
| First authorisation | 10 December 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Trisenox 12 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 27 June 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 10 | Durchstechflasche(n) | L01XX27 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Trisenox 12 mg/6 ml authorised in Switzerland?
Yes. Trisenox 12 mg/6 ml is authorised by Swissmedic under authorisation number 65178, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Trisenox 12 mg/6 ml have?
Trisenox 12 mg/6 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Trisenox 12 mg/6 ml?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.